Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sangamo shares dive after poor early-stage trial data

Sangamo Therapeutics Inc.’s shares sank 27 percent after the company’s gene-editing drug failed to show promise in an early-stage trial testing for patients with ultra-rare disorders.

Read More »

FDA approves Meridian Bioscience’s test for herpes in newborns

The U.S. Food and Drug Administration approved the first test – a diagnostic from Meridian Bioscience Inc. – to help detect a type of herpes virus in newborns.

Read More »

Sivantos and Widex in $8 billion merger

Hearing aid makers Widex and Sivantos are merging to create an industry No. 3 that can invest more in digital devices and step up the challenge to market leaders Sonova and William Demant.

Read More »

Smoking tied to higher risk of hearing loss

Smokers may be more likely to develop hearing loss than nonsmokers, and the risk increases with each additional cigarette people smoke on a typical day, a Japanese study suggests.

Read More »

Cochlear unveils hearing implants that work directly with Apple’s iPhone

Cochlear Ltd. said it can now stream audio directly from Apple Inc.’s iPhone, iPad and iPod to the microchips in its hearing implants without having to use an additional device.

Read More »

Over the counter painkillers linked to hearing loss

Regular use of pain relievers over many years may increase the risk of hearing loss, a recent study suggests.

Read More »

FDA Lifts Clinical Hold On CGF166

GenVec was notified by its collaborator Novartis that FDA has lifted the clinical hold on the Phase 1/2 clinical trial of CGF166 in patients with severe to profound hearing loss.

Read More »

Hearing aids may slow mental decline in hard-of-hearing elderly

(Reuters Health) – Seniors with hearing loss who use hearing aids may experience cognitive decline at a rate more like their peers without hearing trouble, according to a French study that followed thousands of seniors for 25 years. Past research has shown a link between hearing loss and steeper cognitive decline in old age, but […]

Read More »

Third Rock Ventures and GlaxoSmithKline’s SR One Launch Decibel Therapeutics With $52 Million, Expect to Hire 50-60 By Year End

Boston-based Third Rock Ventures announced today it had raised $52 million to launch a company called Decibel Therapeutics to work on hearing loss.   Decibel Therapeutics will be headquartered at 215 First Street in Cambridge, Mass. near Kendall Square. The company has already started to hire, planning on having 50 to 60 scientists working by […]

Read More »

Scientists Show How Exposure To Brief Trauma And Sudden Sounds Form Lasting Memories

NEW YORK, Aug. 24, 2015 /PRNewswire-USNewswire/ — Researchers at NYU Langone Medical Center have found how even brief exposure to sudden sounds or mild trauma can form permanent, long-term brain connections, or memories, in a specific region of the brain. Moreover, the research team, working with rats, says it was able to chemically stimulate those biological […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom